SOURCE: Eternal Technologies Group Inc.

April 19, 2005 14:00 ET

Eternal Technologies Group Announces Filing Delay for Form 10-KSB

HOUSTON, TX -- (MARKET WIRE) -- April 19, 2005 -- Eternal Technologies Group, Inc. (OTC BB: ETLT) today announced that due to the accounting complexity associated with its acquisition of E-Sea Biomedical Engineering Co. International Ltd., it will be filing its year-end 2004 annual financial statements late. The extension will result in an "E" being placed at the end of Eternal's ticker symbol sometime during the week of April 18th. Management however, expects to have the SEC filings completed on or before April 29th, 2005, and to have the "E" removed during the first week of May. The "E" at the end of Eternal's ticker symbol will have no impact on the share structure of Eternal or the ability of investors to buy or sell the common stock of Eternal.

Mr. JiJun Wu, Chairman of the Board of Eternal Technologies Group stated, "Consolidating the financial statements of E-Sea Biomedical Engineering Co. International Ltd. has proven to be more difficult than expected. Although we filed for an extension at the end of March, it became apparent that we would need additional time to ensure the financial accuracy of what has proven to be a very complex matter."

About Eternal Technologies

Eternal is a major agricultural genetics and biopharmaceutical R&D firm operating in China with the support of the Chinese Government. Eternal's animal breeding division has a strong asset base, cash position and net income. Eternal has become one of China's leading institutions for biopharmaceutical and biotech research, pure breed cultivation and breed stock production. The Company has secured a key market niche by commercializing gene engineering technologies and providing superior breeding stock, allowing China's citizens the ability to improve their living standards. With the world's largest population, a double-digit national growth rate and entry into the WTO, Eternal Technologies has a playing field set for tremendous opportunity. As a prominent player in the agricultural genetics industry, cash in the bank and an untapped market, Eternal has the potential to become a major player in China's national growth.

Contact Information